Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$29.5M
+13.9% from 2023
Prescriptions
1,481
$19,940.62 per claim
Patients
221
271 prescribers
Total spending, 2024
$29.5M
$133,629.22 per patient
Medicare prescription drug plans paid $29.5M for Pemazyre in 2024, for 1,481 prescriptions and refills to 221 patients (up 13.9% from 2023). The average cost per claim was $19,940.62.
Texas had the highest Medicare cost for Pemazyre in 2024: $3.1M for 142 claims, followed by New York ($2.4M).
Roberto S Fratamico, hematology-oncology in Allentown, PA, had the highest Medicare cost for Pemazyre in 2024: 13 claims costing $487K.
Pemazyre is made by Incyte Corporation (INCY), listed in the Medicare spending data as Incyte Corporat.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Roberto S Fratamico Allentown, PA | Hematology-Oncology | 13 | Under 11 | $487K |
| James Harding New York, NY | Medical Oncology | 23 | Under 11 | $449K |
| Sunyoung Lee |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 263 | 1,389 | 228 | $25.7M |
| 2023 | 244 | 1,363 | 203 | $25.9M |
| 2024 | 271 | 1,481 | 221 | $29.5M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Medical Oncology |
| 23 |
| Under 11 |
| $401K |
| Leonid Shunyakov Bolivar, MO | Medical Oncology | 22 | Under 11 | $399K |
| Aderonke Ajala State College, PA | Hematology-Oncology | 16 | Under 11 | $339K |
| Leslie A Washburn Rochester, MN | Physician Assistant | 18 | Under 11 | $338K |
| Maria Rachidi Methuen, MA | Physician Assistant | 18 | Under 11 | $333K |
| Mete Korkmaz Rockford, IL | Medical Oncology | 17 | Under 11 | $321K |
| Dequincy A Lewis Asheboro, NC | Hematology-Oncology | 17 | Under 11 | $320K |
| Benjamin R Newton Waterford, CT | Hematology-Oncology | 16 | Under 11 | $305K |
| Rajni Sinha Atlanta, GA | Hematology-Oncology | 16 | Under 11 | $291K |
| Mahendra K Gupta Fargo, ND | Hematology-Oncology | 16 | Under 11 | $288K |
| Manish S Bhandari Edgewood, KY | Medical Oncology | 15 | Under 11 | $283K |
| Umesh A Chitaley Tacoma, WA | Hematology-Oncology | 15 | Under 11 | $283K |
| Gregory H Ripple Lebanon, NH | Medical Oncology | 15 | Under 11 | $282K |
| Mridula Krishnan Omaha, NE | Medical Oncology | 16 | Under 11 | $282K |
| John C McCann Springfield, MA | Hematology-Oncology | 14 | Under 11 | $269K |
| Keerthi Tamragouri Bolingbrook, IL | Hematology-Oncology | 16 | Under 11 | $268K |
| Xiaohong N Jiang Baltimore, MD | Nurse Practitioner | 14 | Under 11 | $267K |
| Justin P Favaro Charlotte, NC | Hematology-Oncology | 14 | Under 11 | $264K |
| Sameek Roychowdhury Columbus, OH | Medical Oncology | 13 | Under 11 | $254K |
| Nadine A Jackson Boston, MA | Medical Oncology | 13 | Under 11 | $249K |
| Manubhai S Patel Jackson, MS | Hematology-Oncology | 13 | Under 11 | $245K |
| Adam R Kuykendal Matthews, NC | Hematology-Oncology | 13 | Under 11 | $244K |
| Michele L Degraw Stony Brook, NY | Nurse Practitioner | 12 | Under 11 | $235K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Incyte Corporat INCY | 1,481 | $29.5M |